# Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer.

> **NCT00209716** · PHASE1,PHASE2 · COMPLETED · sponsor: **Hokkaido Gastrointestinal Cancer Study Group** · enrollment: 30 (estimated)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** Taxotere
- **DRUG:** 5-Fluorouracil
- **DRUG:** Briplatin

## Key facts

- **NCT ID:** NCT00209716
- **Lead sponsor:** Hokkaido Gastrointestinal Cancer Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2009-10
- **Final completion:** 2009-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2010-05-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00209716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00209716, "Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer.". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00209716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*